Fort, L.P. Gilead Sciences, Inc. Transaction History
Fort, L.P.
- $38.5 Million
- Q3 2024
A detailed history of Fort, L.P. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fort, L.P. holds 3,374 shares of GILD stock, worth $382,442. This represents 0.73% of its overall portfolio holdings.
Number of Shares
3,374
Previous 3,420
1.35%
Holding current value
$382,442
Previous $234,000
20.51%
% of portfolio
0.73%
Previous 0.61%
Shares
28 transactions
Others Institutions Holding GILD
# of Institutions
2,101Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$13.1 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.13 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.84 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.57 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $142B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...